---
title: "The concept of innovative drugs rebounds, BHC and HWHG hit the limit up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255705559.md"
description: "The innovative drug concept rebounded. As of the time of publication, BHC and HWHG hit the daily limit, while Boteng Co., Ltd., Rejing Biotech, and Heng Rui Medicine saw significant gains"
datetime: "2025-09-03T02:53:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255705559.md)
  - [en](https://longbridge.com/en/news/255705559.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255705559.md)
generator: "portal-rs"
---

# The concept of innovative drugs rebounds, BHC and HWHG hit the limit up

The innovative drug concept rebounded. As of the time of publication, BHC and HWHG hit the daily limit, while Boteng Co., Ltd., Rejing Biotech, and Heng Rui Medicine saw significant gains

### Related Stocks

- [600721.CN](https://longbridge.com/en/quote/600721.CN.md)
- [600079.CN](https://longbridge.com/en/quote/600079.CN.md)

## Related News & Research

- [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/296117308.md)
- [Baidu: AI Cloud Infra and GPU cloud drove growth and margin gains despite overall revenue decline](https://longbridge.com/en/news/296242242.md)
- [Baidu: AI-powered business growth offset revenue decline, with strong cash flow and global expansion](https://longbridge.com/en/news/296208127.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [Hengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A Shares](https://longbridge.com/en/news/296370263.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**